Invention Application
- Patent Title: RESORCINOL DERIVATIVES
-
Application No.: US15800930Application Date: 2017-11-01
-
Publication No.: US20180170846A1Publication Date: 2018-06-21
- Inventor: Sean D. McAllister , Pierre-Yves Desprez , Anuradha Mahadevan
- Applicant: Sutter West Bay Hospitals
- Main IPC: C07C39/42
- IPC: C07C39/42 ; A61K31/05 ; C07F9/12 ; C07F9/09 ; C07D295/30 ; C07D295/096 ; C07D213/80 ; A61K31/085 ; A61K31/337 ; A61K31/352 ; A61K31/4188 ; A61K31/495 ; A61K45/06 ; C07C39/10 ; C07C39/17 ; C07C39/23 ; C07C43/21 ; C07C43/23 ; C07C69/017 ; C07C69/16 ; C07C69/40 ; C07C271/44 ; C07C309/17
Abstract:
The disclosure relates to cannabinoid derivative compounds, pharmaceutical compositions made thereof, and methods for treating various diseases and disorders including cancer.
Public/Granted literature
- US10202322B2 Resorcinol derivatives Public/Granted day:2019-02-12
Information query
